SBI Securities’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

SBI Securities’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50	Closed	-$27	–	4271
2024 Q4	$27	Buy	+50	New	+$35	﹤0.01%	3774

SBI Securities's MRNS Position: Q1 2025 in Review

SBI Securities sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 50 shares — an estimated $27 sold.

SBI Securities first reported a position in MRNS in Q4 2024 and held it in 1 quarter. The position peaked at $27 in Q4 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

SBI Securities reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
SBI Securities sold 50 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $27.
SBI Securities first reported a position in Marinus Pharmaceuticals, Inc in Q4 2024 and held it in 1 quarter.
SBI Securities's Marinus Pharmaceuticals, Inc position peaked at $27 in Q4 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on SBI Securities's 13F filing for Q1 2025, filed 2 May 2025.